Linda Llewelyn Health Catalyst, Inc. (HCAT) insider trading activity

Linda Llewelyn is Chief People Officer of Health Catalyst, Inc.. Currently has a direct ownership of 112,910 shares of HCAT, which is worth approximately $917,958. The most recent transaction as insider was on Nov 15, 2024, when has been sold 1,365 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $11,602. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 113K

4.75% 3M change

43.77% 12M change

Total Value Held $917,958

Linda Llewelyn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	SELL Open market or private sale	$11,602 $8.5 p/Share	1,365 Reduced 1.19%	112,910 Common Stock
Oct 15 2024	SELL Open market or private sale	$10,803 $8.16 p/Share	1,324 Reduced 1.15%	114,275 Common Stock
Sep 16 2024	SELL Open market or private sale	$11,161 $8.43 p/Share	1,324 Reduced 1.13%	115,599 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$11,726 $7.27 p/Share	1,613 Reduced 1.36%	116,923 Common Stock
Aug 15 2024	SELL Open market or private sale	$8,724 $6.57 p/Share	1,328 Reduced 1.11%	118,536 Common Stock
Jul 15 2024	SELL Open market or private sale	$8,397 $6.51 p/Share	1,290 Reduced 1.06%	119,864 Common Stock
Jun 17 2024	SELL Open market or private sale	$8,217 $6.37 p/Share	1,290 Reduced 1.05%	121,154 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$11,205 $6.53 p/Share	1,716 Reduced 1.38%	122,444 Common Stock
May 15 2024	SELL Open market or private sale	$14,462 $7.0 p/Share	2,066 Reduced 1.64%	124,160 Common Stock
Apr 15 2024	SELL Open market or private sale	$12,250 $6.11 p/Share	2,005 Reduced 1.56%	126,226 Common Stock
Mar 15 2024	SELL Open market or private sale	$15,639 $7.8 p/Share	2,005 Reduced 1.54%	128,231 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$27,683 $8.05 p/Share	3,439 Reduced 2.57%	130,236 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	68,889 Added 34.01%	133,675 Common Stock
Feb 15 2024	SELL Open market or private sale	$31,869 $9.77 p/Share	3,262 Reduced 4.79%	64,786 Common Stock
Jan 16 2024	SELL Open market or private sale	$34,255 $10.83 p/Share	3,163 Reduced 4.44%	68,048 Common Stock
Dec 15 2023	SELL Open market or private sale	$27,929 $8.83 p/Share	3,163 Reduced 4.25%	71,211 Common Stock
Dec 01 2023	SELL Payment of exercise price or tax liability	$30,999 $7.45 p/Share	4,161 Reduced 5.3%	74,374 Common Stock
Nov 15 2023	SELL Open market or private sale	$9,867 $8.25 p/Share	1,196 Reduced 1.5%	78,535 Common Stock
Oct 16 2023	SELL Open market or private sale	$9,671 $8.33 p/Share	1,161 Reduced 1.44%	79,731 Common Stock
Sep 15 2023	SELL Open market or private sale	$12,771 $11.01 p/Share	1,160 Reduced 1.41%	80,892 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$17,481 $11.78 p/Share	1,484 Reduced 1.78%	82,052 Common Stock
Aug 22 2023	SELL Open market or private sale	$8,770 $11.9 p/Share	737 Reduced 0.87%	83,536 Common Stock
Jun 01 2023	SELL Payment of exercise price or tax liability	$17,399 $11.24 p/Share	1,548 Reduced 1.8%	84,273 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$24,778 $14.29 p/Share	1,734 Reduced 2.06%	82,311 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	35,000 Added 29.4%	84,045 Common Stock

Linda Llewelyn

Chief People Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account